Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|September 25, 1999
Molecular analysis of yeast and human type II topoisomerases. Enzyme-DNA and drug interactionsD Strumberg, J L Nitiss, J Dong, et al.
The Journal of Biological Chemistry|March 6, 1999
Mutation of a conserved serine residue in a quinolone-resistant type II topoisomerase alters the enzyme-DNA and drug interactionsD Strumberg, J L Nitiss, A Rose, et al.
Molecular and Cellular Biology|May 11, 2000
Conversion of topoisomerase I cleavage complexes on the leading strand of ribosomal DNA into 5'-phosphorylated DNA double-strand breaks by replication runoffD Strumberg, A A Pilon, M Smith, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2011
Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumorsB Schultheis, G Kummer, M Zeth, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|September 25, 2015
Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasisC Demtröder, W Solass, J Zieren, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinomaD Strumberg, J Erhard, A Harstrick, et al.
Anti-Cancer Drugs|March 1, 1997
Phase II trial of continuous oral trofosfamide in patients with advanced colorectal cancer refractory to 5-fluorouracilD Strumberg, A Harstrick, U Klaassen, et al.
Leukemia|May 1, 1994
Structural analysis of the deoxycytidine kinase gene in patients with acute myeloid leukemia and resistance to cytosine arabinosideM Flasshove, D Strumberg, L Ayscue, et al.
Journal of Medicinal Chemistry|October 6, 2000
Synthesis of new indeno[1,2-c]isoquinolines: cytotoxic non-camptothecin topoisomerase I inhibitorsM Cushman, M Jayaraman, J A Vroman, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysisU Klaassen, H Wilke, C P Pari, et al.
Pageof 5